NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Narayana Hrudayalaya Schedules NCLT-Directed Meetings on Jan 19, 2026, for MMRHL Merger
Narayana Hrudayalaya (NH) has scheduled NCLT-convened meetings on January 19, 2026, to seek approval for the amalgamation of its subsidiary, Meridian Medical Research & Hospital Ltd. (MMRHL), with itself. The meetings will involve equity shareholders, secured creditors, and unsecured creditors of both entities via video conferencing. This follows the NCLT Bengaluru Bench order dated December 2, 2025, and prior approvals from BSE and NSE in June 2025. The merger is intended to streamline the corporate structure and integrate subsidiary operations directly into the parent company.
முக்கிய அம்சங்கள்
NCLT-directed meetings for shareholders and creditors are scheduled for January 19, 2026.The merger involves the total integration of subsidiary Meridian Medical Research & Hospital Ltd. into NH.Remote e-voting for shareholders is set to take place between January 16 and January 18, 2026.The scheme previously received observation letters from BSE and NSE on June 23 and June 24, 2025, respectively.The cut-off date for determining eligibility for e-voting is January 12, 2026.
👀 கவனிக்க வேண்டியவை
Investors should monitor the voting results of the January 19 meeting as the merger will consolidate financials and simplify the group structure. Shareholders as of the January 12 cut-off date are encouraged to participate in the e-voting process.
NH to Hold Shareholder Meeting on Jan 19, 2026 for Merger with Subsidiary MMRHL
Narayana Hrudayalaya (NH) has scheduled a meeting for its equity shareholders and creditors on January 19, 2026, to approve the merger of its subsidiary, Meridian Medical Research & Hospital Ltd. (MMRHL), into the parent company. This follows an order from the NCLT Bengaluru Bench dated December 02, 2025. Remote e-voting for the resolution will be open from January 16 to January 18, 2026. The amalgamation is intended to simplify the corporate structure and integrate the subsidiary's operations directly into NH.
முக்கிய அம்சங்கள்
NCLT-directed shareholder meeting scheduled for January 19, 2026, at 12:00 Noon via VC/OAVM.Amalgamation of subsidiary Meridian Medical Research & Hospital Ltd. with Narayana Hrudayalaya Ltd.Remote e-voting period set from January 16, 2026 (9:00 AM) to January 18, 2026 (5:00 PM).Cut-off date for determining eligibility for e-voting is January 12, 2026.SEBI observation letters from BSE and NSE were previously obtained in June 2025.
👀 கவனிக்க வேண்டியவை
Shareholders should participate in the e-voting process between January 16-18 to support the corporate restructuring. This merger is a positive step toward operational consolidation and administrative cost reduction.
NHPC Completes Successful Trial Run of 250 MW Unit #2 at Subansiri Lower Project
NHPC Limited has achieved a significant milestone with the successful trial run of Unit #2 (250 MW) at its Subansiri Lower Hydroelectric Project on December 18, 2025. This project, located on the Assam/Arunachal Pradesh border, is a massive 2,000 MW undertaking comprising eight units of 250 MW each. The completion of this trial run indicates that the project is moving steadily toward commercial operations after various historical delays. This development is expected to eventually contribute significantly to NHPC's power generation capacity and revenue stream.
முக்கிய அம்சங்கள்
Successful trial run of Unit #2 with 250 MW capacity completed on December 18, 2025.Subansiri Lower HE Project has a total installed capacity of 2,000 MW (8 x 250 MW units).The project is a critical asset for NHPC located at the Assam and Arunachal Pradesh border.Trial run completion marks a key step toward full commercial commissioning of the unit.
👀 கவனிக்க வேண்டியவை
Investors should maintain a positive outlook as NHPC nears the monetization of its largest project; monitor for the official Commercial Operation Date (COD) announcement.
Can Fin Homes Declares Interim Dividend of Rs 7 Per Share; Sets Record Date for Dec 19
Can Fin Homes has declared an interim dividend of Rs 7 per equity share for the financial year 2025-26, which is a 350% payout on the face value of Rs 2. The company has established December 19, 2025, as the record date to identify eligible shareholders for this payment. The dividend is scheduled to be credited or dispatched to shareholders on or before January 13, 2026. Investors are reminded that this dividend is taxable, and the company will deduct TDS based on the shareholder's residential status and submitted documentation.
முக்கிய அம்சங்கள்
Interim dividend of Rs 7 per equity share declared for the financial year 2025-26Record date for determining eligibility is fixed as December 19, 2025Dividend payment to be completed on or before January 13, 2026Deadline for submitting tax exemption documents is December 22, 2025Mandatory electronic payment mode implemented in compliance with SEBI circulars
👀 கவனிக்க வேண்டியவை
Investors should ensure their bank account details are updated with their Depository Participant to receive the dividend electronically. Those eligible for tax exemptions should submit the necessary forms by December 22 to avoid standard TDS rates.
Can Fin Homes Declares ₹7 Interim Dividend and Re-appoints Suresh Iyer as MD & CEO
Can Fin Homes has declared an interim dividend of ₹7.00 per equity share (350% of face value) for FY 2025-26, with the record date set for December 19, 2025. The Board also approved the re-appointment of Suresh Srinivasan Iyer as MD & CEO for a further two-year term starting March 18, 2026. This leadership continuity is subject to RBI approval, for which an application has already been submitted. The dividend is expected to be credited to eligible shareholders by January 13, 2026.
முக்கிய அம்சங்கள்
Declared an interim dividend of ₹7.00 per equity share (350% of ₹2 face value).Fixed December 19, 2025, as the record date for determining dividend eligibility.Re-appointed Suresh Srinivasan Iyer as MD & CEO for a 2-year term effective March 18, 2026.The MD re-appointment is pending prior approval from the Reserve Bank of India (RBI).Suresh Iyer brings over 25 years of specialized experience from Gruh Finance and Bandhan Bank.
👀 கவனிக்க வேண்டியவை
Investors should ensure they hold shares before the December 19 record date to qualify for the ₹7 dividend and can view the MD's re-appointment as a positive sign of leadership stability.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Narayana Hrudayalaya (NH): Demerger of Clinical Services Approved
Narayana Hrudayalaya Ltd. (NH) has announced the approval of a scheme of arrangement involving the demerger of the Clinical Services undertaking from NH Integrated Care Private Limited (NHIC) into Narayana Hrudayalaya Limited (NHL). The turnover of the Clinical Services undertaking for the year ended March 31, 2025, was ₹39.94 crore, representing 1.11% of NHL's total standalone turnover. This demerger aims to allow NHIC to focus on preventive healthcare and transfer clinical services to NHL for unified patient care pathways. NHL shall continue to hold 100% of equity share capital of NHIC.
முக்கிய அம்சங்கள்
Demerger of Clinical Services undertaking of NH Integrated Care Private Limited (NHIC) into Narayana Hrudayalaya Limited (NHL).Turnover of the Clinical Services undertaking for the year ended March 31, 2025 was ₹39.94 crore.Clinical Services turnover represents 1.11% of the total standalone turnover of the Resulting Company for the year ended March 31, 2025.NHL will continue to hold 100% of equity share capital of NHIC.
👀 கவனிக்க வேண்டியவை
Investors should monitor the progress of the scheme, including regulatory approvals and NCLT approval. The impact on Narayana Hrudayalaya's financials will likely be minor given the small size of the demerged entity.
Narayana Hrudayalaya Ltd. (NHL) has approved a scheme of arrangement to demerge the Clinical Services undertaking from its wholly-owned subsidiary, NH Integrated Care Private Limited (NHIC). The turnover of the demerged Clinical Services undertaking was ₹39.94 crore for the year ended March 31, 2025, representing 1.11% of NHL's total standalone turnover. NHL will consolidate administrative functions and optimize resource deployment. There will be no change in the shareholding pattern of NHL as a result of this demerger.
முக்கிய அம்சங்கள்
Demerger of Clinical Services undertaking from NH Integrated Care Private Limited (NHIC) to Narayana Hrudayalaya Limited (NHL).Turnover of the Clinical Services undertaking was ₹39.94 crore for the year ended March 31, 2025.Clinical Services turnover represents 1.11% of the total standalone turnover of NHL for the year ended March 31, 2025.Appointed Date for the Scheme is April 1, 2025.
👀 கவனிக்க வேண்டியவை
Investors should monitor the progress of the scheme, including receipt of regulatory approvals and NCLT approval. The demerger is expected to improve operational efficiency and unlock value.
India Ratings Upgrades Can Fin Homes Long-Term Rating to 'IND AAA' with Stable Outlook
India Ratings (Ind-Ra) has upgraded Can Fin Homes' long-term issuer rating to 'IND AAA' from 'IND AA+', the highest possible credit rating. This upgrade follows a change in rating approach after the RBI lifted restrictions on overlapping business lines, strengthening the expectation of support from parent Canara Bank. The company maintains a healthy AUM of INR 396.57 billion with a stable Return on Average Assets (RoAA) of 2.3%. While leverage remains higher than peers at 6.7x, it has shown a consistent downward trend from 8.2x in FY22.
முக்கிய அம்சங்கள்
Long-Term Issuer Rating upgraded to 'IND AAA' from 'IND AA+' with a Stable outlook.Assets Under Management (AUM) grew 8.4% YoY to INR 396.57 billion as of September 2025.Gross Stage 3 assets remain well-controlled at 0.94% with Net Stage 3 at 0.50%.Net Interest Margin (NIM) improved to 4% in 1HFY26 from 3.7% in FY25.Liquidity remains adequate with unutilised bank facilities and working capital limits of INR 99.68 billion.
👀 கவனிக்க வேண்டியவை
The upgrade to AAA status is a significant milestone that will likely reduce the company's cost of borrowing and improve competitive positioning. Investors should view this as a de-risking event that reinforces the company's financial stability and strong parentage support.
Can Fin Homes declares Record Date for Interim Dividend: 19-Dec-2025
Can Fin Homes Limited has announced a record date of December 19, 2025, for determining shareholders' eligibility for an interim dividend for the financial year 2025-26. The decision regarding the declaration and payment of this interim dividend will be made during a Board of Directors meeting scheduled for December 15, 2025. Trading window for designated persons is closed from December 8, 2025, until December 17, 2025. Investors should note this date to be eligible for the dividend if declared.
முக்கிய அம்சங்கள்
Record date for interim dividend is December 19, 2025Board meeting to consider interim dividend on December 15, 2025Trading window closed from December 8, 2025, to December 17, 2025Interim Dividend pertains to FY 2025-26
👀 கவனிக்க வேண்டியவை
Shareholders should note the record date of December 19, 2025, to be eligible for the interim dividend if declared. Monitor the outcome of the board meeting on December 15, 2025, for the dividend declaration.
NHPC Synchronizes 250 MW Unit of Subansiri Lower Project with National Grid
NHPC Limited has successfully achieved the test synchronization of Unit #2 (250 MW) of its 2000 MW Subansiri Lower Hydroelectric Project with the national grid on December 2, 2025. This is a critical milestone for the mega-project, which has faced several delays in the past. The company expects to start Commercial Operation (CoD) for this specific unit within December 2025. This development signals that the project is finally nearing phased operationalization, which will eventually contribute significantly to the company's top-line growth.
முக்கிய அம்சங்கள்
Successful test synchronization of 250 MW Unit #2 achieved on December 2, 2025Subansiri Lower HE Project has a total planned capacity of 2000 MWCommercial Operation (CoD) of Unit #2 is expected to commence in December 2025The project is a major capacity addition for NHPC, being one of India's largest hydro projects
👀 கவனிக்க வேண்டியவை
Investors should maintain a positive outlook as the company begins to monetize its massive capital expenditure in the Subansiri project. Monitor for the final Commercial Operation Date (CoD) announcement later this month.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
